Medicare utilization — JEFFREY ROSS CUSMARIU (MD)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 6,216 | 13 | $0 | $3,536 |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 928 | 19 | $0 | $12,277 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 278 | 83 | $0 | $1,443 |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 158 | 113 | $0 | $9,378 |
| 20610 | Aspiration and/or injection of fluid from large joint | 91 | 59 | $0 | $4,514 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·